Assignee
SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD
CN·10 granted patents·10 pending applications·16 citations·filing 2013–2023
Top patents by PatentIndex Score
20 records- 0191US11459327B1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 4, 2022·6 cites·6 claims
- 0277US9809572B2Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compoundsSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Nov 7, 2017·5 cites·16 claims
- 0372US9604935B2Deuterated phenyl amino pyrimidine compound and pharmaceutical composition containing the sameSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Mar 28, 2017·3 cites·11 claims
- 0467US10544185B2Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 0565US10377725B2Phenyl amino pyrimidine compound or polymorph of salt thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Aug 13, 2019·1 cites·15 claims
- 0663US2023105745A1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0763US2025206758A1Substituted bridged ring inhibitor, preparation method therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0863US2026015363A1Substituted pyrimidine-fused ring inhibitor, method for preparing same, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0961US2025051444A1Multi-specific t cell engagers comprising lrrc15 antigen-binding domainSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1058US9573900B2Polymorphs of deuterated omega-diphenylurea or salts thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2013·Granted Feb 21, 2017·0 cites·20 claims
- 1155US9889123B2Polymorphs of deuterated omega-diphenylurea or salts thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Feb 13, 2018·0 cites·7 claims
- 1254US12583935B2Anti-human CD47 antibody and antigen-binding fragment thereof, and preparation method therefor and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Mar 24, 2026·0 cites·19 claims
- 1354US10618884B2Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compoundsSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Apr 14, 2020·0 cites·18 claims
- 1453US2024336606A1Substituted benzo or pyridopyrimidine amine inhibitor, preparation method therefor, and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1552US2023118795A1Aryl or heteroaryl pyridone or pyrimidine derivative, preparation method and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1652US2023008368A1Imidazoquinoline substituted phosphoric ester agonist, and preparation therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1751US2025376449A1Preparation process for jaktinib dihydrochloride monohydrateSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1847US2022162256A1Method for preparing chenodeoxycholic acid derivativeSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1946US2023109134A1Pyridazinone or pyridazine compound and derivative and pharmaceutical composition thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2033US10414767B2Deuterated quinazolinone compound and pharmaceutical composition comprising sameSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2015·Granted Sep 17, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →